Walleye Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19,408
Closed -$27.6K 4548
2022
Q4
$27.6K Buy
+19,408
New +$41.6K ﹤0.01% 2621
2022
Q3
Sell
-829,973
Closed -$1.88M 3665
2022
Q2
$1.88M Buy
+829,973
New +$3.09M 0.05% 381
2021
Q4
Sell
-15,663
Closed -$158 2415
2021
Q3
$158 Buy
+15,663
New +$172K ﹤0.01% 1235
2020
Q4
Sell
-19,566
Closed -$149K 1161
2020
Q3
$149K Sell
19,566
-3,700
-16% -$27.2K 0.02% 665
2020
Q2
$141K Buy
+23,266
New +$115K 0.03% 477
2019
Q3
Sell
-6,400
Closed -$75.8K 2358
2019
Q2
$59K Sell
6,400
-30,794
-83% -$321K 0.01% 1348
2019
Q1
$412K Buy
+37,194
New +$260K 0.07% 456

Other funds holding DBD

Walleye Capital's DBD Position: Q1 2023 in Review

Walleye Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 19,408 shares — an estimated $27.6K sold.

Walleye Capital first reported a position in DBD in Q1 2019 and held it in 7 quarters. The position peaked at $1.88M in Q2 2022. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • Walleye Capital reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 19,408 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $27.6K.
  • Walleye Capital first reported a position in Diebold Nixdorf Incorporated in Q1 2019 and held it in 7 quarters.
  • Walleye Capital's Diebold Nixdorf Incorporated position peaked at $1.88M in Q2 2022.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.